Ketotifen Al (Ketotifen Hydrogen Fumarate)

Ketotifen works by stabilizing mast cells, which prevents the release of histamine and other inflammatory mediators. In addition, it blocks H1 histamine receptors, reducing the vascular and smooth‑muscle responses that cause typical allergy symptoms.

The dose of ketotifen is individualized by the prescribing clinician based on the patient’s age, severity of symptoms, and overall health. Healthcare providers determine the appropriate strength, frequency and duration of therapy for each case.

Safety data for ketotifen during pregnancy and lactation are limited. It should be used only when the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the Ketotifen Al product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ketotifen combines mast‑cell stabilization with H1‑receptor blockade, offering both immediate symptom relief and longer‑term control. Compared with many first‑generation antihistamines, it may cause less sedation, while providing additional prophylactic benefits for asthma that some other antihistamines lack.

Ketotifen Al tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original packaging, protect from moisture and direct light, and ensure they are out of reach of children.

Ketotifen Al is taken orally, usually with a glass of water. The tablet should be swallowed whole and not chewed or crushed unless specifically instructed by a healthcare professional.

Serious adverse reactions include severe skin conditions such as Stevens‑Johnson syndrome, hepatic dysfunction, cardiac arrhythmias, and rare cases of anaphylaxis. Patients should seek immediate medical attention if they notice rash, jaundice, irregular heartbeat, or signs of an allergic reaction.

Ketotifen is contraindicated in individuals with known hypersensitivity to the drug or any of its components. Caution is advised for patients with narrow‑angle glaucoma, severe hepatic impairment, or those taking interacting medications listed under major interactions.